AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)
$4.17 -0.04 (-0.9501%)
Analysed AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) News Sources
Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know
06-05-2026
yahoo.com
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates
07-05-2026
yahoo.com
Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree
12-05-2026
yahoo.com
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
13-05-2026
yahoo.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
13-05-2026
yahoo.com
Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates
13-05-2026
yahoo.com
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
13-05-2026
yahoo.com
Aquestive Therapeutics Q1 Earnings Call Highlights
14-05-2026
marketbeat.com
Aquestive Therapeutics Inc (AQST) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
14-05-2026
yahoo.com
The Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Are Out And Analysts Have Published New Forecasts
15-05-2026
yahoo.com
What is the current price of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)?
The current price of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) is $4.17.
AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) absolute price change since previous trading day?
The absolute price change of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) since the previous trading day is $-0.04.
AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) percentage price change since previous trading day?
The percentage price change of AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) since the previous trading day is -0.9501%.
What is the most recent average sentiment score for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)?
The most recent average sentiment score for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)?
The most recent sentiment for AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ) is .
SEC-8K** Filing Available For AQUESTIVE THERAPEUTICS INC (AQST:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.